Clinical Trial Update: First Study in Humans With GSK206136 [Phase 1]

View source ↗

Summary

This document reports the first-in-human Phase 1 study of GSK206136. The trial investigating depressive disorder and anxiety disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Drugs mentioned

• GSK206136

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder and Anxiety Disorders | Phase 1 | Status: COMPLETED